Possible contribution of platelet cyclooxygenase to the renal vascular action of 5,6-epoxyeicosatrienoic acid

D Fulton, M Balazy, JC McGiff and J Quilley

Department of Pharmacology, New York Medical College, Valhalla, USA.

5,6-Epoxyeicosatrienoic acid (5,6-EET), a cytochrome P450-dependent arachidonate product, is a substrate for cyclooxygenase (COX) and, in some vascular preparations, elicits COX-dependent vasodilation. In the blood perfused rat kidney, 5,6-EET causes COX-dependent renal vasoconstriction, whereas in the rat isolated kidney perfused with a physiological buffer, 5,6-EET produces dose-dependent vasodilation that is unaffected by indomethacin. We examined the possible contribution of platelet COX to the vasoconstrictor action of 5,6-EET. Incubation of labeled 5,6-EET with rat washed platelets yields additional products that elute between 14 to 17 min on high-performance liquid chromatography (HPLC) and cause constriction of the perfused kidney. Indomethacin decreased the formation of these products and reduced the vasoconstrictor capacity of the corresponding HPLC fractions. Thus, platelet COX can metabolize 5,6-EET to vasoconstrictor products that may contribute to the in vivo vasoconstrictor effect of this eicosanoid.

Volume 277, Issue 3, pp. 1195-1199, 06/01/1996
Copyright © 1996 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				K. T. Moreland, J. D. Procknow, R. S. Sprague, J. L. Iverson, A. J. Lonigro, and A. H. Stephenson Cyclooxygenase (COX)-1 and COX-2 Participate in 5,6-Epoxyeicosatrienoic Acid-Induced Contraction of Rabbit Intralobar Pulmonary Arteries J. Pharmacol. Exp. Ther., May 1, 2007; 321(2): 446 - 454. [Abstract] [Full Text] [PDF]

				J. D. Imig Epoxide hydrolase and epoxygenase metabolites as therapeutic targets for renal diseases Am J Physiol Renal Physiol, September 1, 2005; 289(3): F496 - F503. [Abstract] [Full Text] [PDF]

				H. Jiang, J. C. McGiff, J. Quilley, D. Sacerdoti, L. M. Reddy, J. R. Falck, F. Zhang, K. M. Lerea, and P. Y-K Wong Identification of 5,6-trans-Epoxyeicosatrienoic Acid in the Phospholipids of Red Blood Cells J. Biol. Chem., August 27, 2004; 279(35): 36412 - 36418. [Abstract] [Full Text] [PDF]

				G. O. Ogungbade, L. A. Akinsanmi, H. Jiang, and A. O. Oyekan Role of epoxyeicosatrienoic acids in renal functional response to inhibition of NO production in the rat Am J Physiol Renal Physiol, November 1, 2003; 285(5): F955 - F964. [Abstract] [Full Text] [PDF]

				A. H. Stephenson, R. S. Sprague, J. L. Losapio, and A. J. Lonigro Differential effects of 5,6-EET on segmental pulmonary vasoactivity in the rabbit Am J Physiol Heart Circ Physiol, June 1, 2003; 284(6): H2153 - H2161. [Abstract] [Full Text] [PDF]

				J. D. Imig Eicosanoid regulation of the renal vasculature Am J Physiol Renal Physiol, December 1, 2000; 279(6): F965 - F981. [Abstract] [Full Text] [PDF]

				J. H. Capdevila, J. R. Falck, and R. C. Harris Cytochrome P450 and arachidonic acid bioactivation: molecular and functional properties of the arachidonate monooxygenase J. Lipid Res., February 1, 2000; 41(2): 163 - 181. [Abstract] [Full Text]

				J. C. McGiff and J. Quilley 20-HETE and the kidney: resolution of old problems and new beginnings Am J Physiol Regulatory Integrative Comp Physiol, September 1, 1999; 277(3): R607 - R623. [Abstract] [Full Text] [PDF]

				A. H. Stephenson, R. S. Sprague, and A. J. Lonigro 5,6-Epoxyeicosatrienoic acid reduces increases in pulmonary vascular resistance in the dog Am J Physiol Heart Circ Physiol, July 1, 1998; 275(1): H100 - H109. [Abstract] [Full Text] [PDF]

				D. Fulton, J. C. McGiff, M. S. Wolin, P. Kaminski, and J. Quilley Evidence against a Cytochrome P450-Derived Reactive Oxygen Species as the Mediator of the Nitric Oxide-Independent Vasodilator Effect of Bradykinin in the Perfused Heart of the Rat J. Pharmacol. Exp. Ther., February 1, 1997; 280(2): 702 - 709. [Abstract] [Full Text]